SHARE PRICE > View All Stock Detailed Share Information Latest News Molecular Partners Announces Publication in Nature Biotechnology Detailing Design and Mechanism of Ensovibep DARPin Antiviral for SARS-CoV-2 Molecular Partners Announces Participation in Scientific Conferences Interim Management Statement Q1 2022 of Molecular Partners: Cash Runway into 2026 and Portfolio Progress Highlight Strategic Momentum > View All News All News Upcoming Events August 25, 2022 H1 2022 report August 26, 2022 at 8:00 AM EDT Publication of Half-year Results 2022 (unaudited) October 27, 2022 Interim Management Statement Q3 2022 > View All Events All Events Latest Presentation June 15, 2022 MP Corporate Presentation April 25, 2022 Kempen Conference Presentation March 16, 2022 Publication of full year results 2021 > View All Presentations All Presentations Latest Financial Documents May 12, 2022 Q1 2022 Financial Statement March 15, 2022 Annual Report FY2021 October 28, 2021 Q3 2021 Financial Statement > View All Reports All Annual Report Seth Lewis, SVP Investor Relations, Communications and Strategy Contact Seth STAY INFORMED Subscribe to email alerts of your choosing SUBSCRIBE Institutional investors: REQUEST 1-1 / CALL powered by schedulR
Molecular Partners Announces Publication in Nature Biotechnology Detailing Design and Mechanism of Ensovibep DARPin Antiviral for SARS-CoV-2
Interim Management Statement Q1 2022 of Molecular Partners: Cash Runway into 2026 and Portfolio Progress Highlight Strategic Momentum
